ADMA Biologics

ADMA Mid Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$9.19

+0.88% heute

52W: $7.21 – $25.67

52W Low: $7.21 Position: 10.7% 52W High: $25.67

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

15.32x

Kurs/Gewinn-Verhältnis

Forward P/E

6.66x

Erwartetes KGV

P/S Ratio

4.29x

Kurs/Umsatz-Verhältnis

EV/EBITDA

220.19x

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$2.2B

Marktkapitalisierung

Umsatzwachstum

15.9%

YoY Umsatzwachstum

Gewinnmarge

28.8%

Nettomarge

ROE

35.56%

Eigenkapitalrendite

Beta

0.82

Marktsensitivität

Short Interest

13.32%

% der Aktien leerverkauft

Ø Volumen

4,986,977

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

Unterbewertet

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Kaufen

2 Analysten

Ø Kursziel

$23.50

+155.71% Upside

Kursziel Spanne

$17.00 – $30.00

Über das Unternehmen

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treat

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 640 Börse: NGM

Trading-Daten

50-Day MA: $14.96

200-Day MA: $16.60

Volumen: 6,124,364

Ø Volumen: 4,986,977

Short Ratio: 7.16

Kurs/Buchwert: 4.58x

Verschuldung/EK: 110.67x

Free Cash Flow: $-18,154,876

Wo kann ich ADMA Biologics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →